Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 5;23(11):2878.
doi: 10.3390/molecules23112878.

Anti-Leishmanial and Cytotoxic Activities of a Series of Maleimides: Synthesis, Biological Evaluation and Structure-Activity Relationship

Affiliations

Anti-Leishmanial and Cytotoxic Activities of a Series of Maleimides: Synthesis, Biological Evaluation and Structure-Activity Relationship

Yongxian Fan et al. Molecules. .

Abstract

In the present study, 45 maleimides have been synthesized and evaluated for anti-leishmanial activities against L. donovani in vitro and cytotoxicity toward THP1 cells. All compounds exhibited obvious anti-leishmanial activities. Among the tested compounds, there were 10 maleimides with superior anti-leishmanial activities to standard drug amphotericin B, and 32 maleimides with superior anti-leishmanial activities to standard drug pentamidine, especially compounds 16 (IC50 < 0.0128 μg/mL) and 42 (IC50 < 0.0128 μg/mL), which showed extraordinary efficacy in an in vitro test and low cytotoxicities (CC50 > 10 μg/mL). The anti-leishmanial activities of 16 and 42 were 10 times better than that of amphotericin B. The structure and activity relationship (SAR) studies revealed that 3,4-non-substituted maleimides displayed the strongest anti-leishmanial activities compared to those for 3-methyl-maleimides and 3,4-dichloro-maleimides. 3,4-dichloro-maleimides were the least cytotoxic compared to 3-methyl-maleimides and 3,4-non-substituted maleimides. The results show that several of the reported compounds are promising leads for potential anti-leishmanial drug development.

Keywords: Leishmania donovani; SAR; anti-leishmanial activity; cytotoxicity; maleimides.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
Synthesis of N-substituted maleimide derivatives. Path A: a. CH3COOH. Path B: b. toluene, 25–65 °C, 2–8 h; c. CH3COONa, (Et)3N, 101 °C, 10–24 h.
Figure 1
Figure 1
Chemical structures of the studied N-substituted maleimides.
Figure 2
Figure 2
The chemical structure of pentamidine.
Figure 3
Figure 3
The chemical structure of amphotericin B.

Similar articles

Cited by

References

    1. World Health Organization. [(accessed on 1 September 2017)]; Available online: www.who.int/leishmaniasis/burden/en/
    1. Akopyants N.S., Kimblin N., Secundino N., Patrick R., Peters N., Lawyer P., Dobson D.E., Beverley S.M., Sacks D.L. Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector. Science. 2009;324:265–268. doi: 10.1126/science.1169464. - DOI - PMC - PubMed
    1. Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R.W., Alvar J., Boelaert M. Visceral leishmaniasis: What are the needs for diagnosis, treatment and control. Nat. Rev. Microbiol. 2007;5:873–882. doi: 10.1038/nrmicro1748. - DOI - PubMed
    1. Sharma U., Singh S. Immunobiology of leishmaniasis. Indian J. Exp. Biol. 2009;47:412–423. - PubMed
    1. Golenser J., Domb B. New formulations and derivatives of amphotericin B for treatment of leishmaniasis. Mini-Rev. Med. Chem. 2006;6:153–162. doi: 10.2174/138955706775476037. - DOI - PubMed

MeSH terms

LinkOut - more resources